Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2016.447 | Adenoma detection rate in colonoscopies after fecal immunochemical testing – a retrospective analysis of a multicenter cohort of 10,000 asymptomatic subjects (ADR FIT study) | Dr. WONG John Chi To |
| 2015.005 | The stress-reducing effects of therapeutic play on children undergoing cast-removal procedure. | Dr. Wong JoJo Cho Lee |
| 2015.345 | A comprehensive prospective assessment of the physical and biological effects of patients with kidney cancer in Hong Kong |
Dr. WONG Joseph Hon Ming 黄翰明 |
| 2015.347 | A comprehensive retrospective assessment of the physical and biological effects of patients with kidney cancer in Hong Kong |
Dr. WONG Joseph Hon Ming 黄翰明 |
| 2026.483 | Reconstructive Strategies for Small to Medium Intraoral Defects: A Decade of Posterior Buccinator Myomucosal Flap Use in a Tertiary Referral Center |
Dr. Wong Justin Tze Tao Justin Wong |
| 2026.484 | Treatment Efficacy, Safety, and Feasibility of Ethanol Ablation for Thyroglossal Duct Cysts in Hong Kong | Dr. Wong Justin Tze Tao |
| 2026.370 | Solid tissue derived extracellular vesicles in thyroid, A feasibility pilot study | Dr. Wong Justin Tze Tao |
| 2017.619 | Reliability and validity of Hong Kong version of Hierarchic Dementia Scale-Revised (HDS-R-HK) |
Miss WONG Ka Chun 黃嘉珍 |
| 2019.308 | Clinical and socio-demographic risk factors for antibacterial resistance of Helicobacter pylori in Hong Kong |
Dr. WONG Ka Hei 黃嘉曦 |
| 2018.224 | A trial of low FODMAP diet in patients with functional dyspepsia |
Dr. WONG Ka Hei 黃嘉曦 |
| 2020.470 | A retrospective analysis of Helicobacter pylori eradication rate by Clarithromycin based therapy in Hong Kong |
Dr. WONG Ka Hei 黃嘉曦 |
| 2025.217 | Usage, response and tolerance of mTOR inhibitor for Tuberous Sclerosis Complex (TSC) patients in Hong Kong | Dr. WONG Ka Nam |
| 2011.455 | Relationship between health status and burden of dementia caregiver in Hong Kong. Cross-sectional study. | RN(Psy) Wong Ka Po |
| 2013.067 | Clinical application and values of cerebrovascular hemodynamics assessment in patients with large artery stenosis | Prof. WONG Ka Sing |
| 2013.396 | CHA2DS2-VASc is better than CHADS2 at predicting clinical outcomes of ischemic stroke in Chinese patients with atrial fibrillation | Prof. Wong Ka Sing |
| 2012.235 | Effects of combining External Counterpulsation Therapy and Intermittent Theta Burst Stimulation on Corticomotor Excitability in healthy adults | Prof. WONG Ka Sing |
| 2013.095 | Assessment of infarct-induced changes of brain perfursion and metabolism using novel structural and functional MRI sequences to measure treatment efficiency | Prof. Wong Ka Sing |
| 2009.384 | Relationship between Autonomic Dysfunction and Artery Structure Change | Prof. Wong Ka Sing |
| 2013.397 | Autonomic Dysfunction as Measured by Ewing’s Battery Test to Predict Poor Outcome after Acute Ischemic Stroke | Prof. WONG Ka Sing |
| 2012.501 | Intracranial Artery Calcification Score on Computed Tomography: A non-invasive predictos to screen Chinese Stroke patients at high risk of recurrent stroke | Prof. WONG Ka Sing |
| 2016.353 | A Randomized, Controlled Study of External Counterpulsation for Patients with Impaired Cerebral Autoregulation following Symptomatic Intracranial Artery Stenosis |
Prof. WONG Ka Sing 黃家星 |
| 2014.247 | Using a Novel and Noninvasive Cerebral Augmentation Index as Evaluated by External Counterpulsation to Predict Long-term Clinical Outcome after Acute Ischemic Stroke | Prof. WONG Ka Sing |
| 2013.587 | Quantitative Evaluation of the Efficacy of Herbs in Ischemic Stroke Patients Using Diffusion Tensor Imaging | Prof. WONG Ka Sing |
| 2012.514 | A randomized controlled trial of transcranial magnetic stimulation and robotic-hand therapy to improve hand function after ischemic stroke | Prof. WONG Ka Sing |
| 2020.231 | Radiological findings of COVID-19 infection |
Dr. WONG Ka Tak 黃嘉德 |
| 2020.216 | Development of machine learning and artificial intelligence model for detection and prognostication of COVID-19 | Dr. WONG Ka Tak |
| 2009.113 | The Perception on Public Health Care Services Quality: An Overview of Patient Satisfaction to A Public General Out Patient Clinic (GOPC) | Mr. Wong Ka Wing |
| 2014.355 | Fall prevention strategies among older fallers who are indwelling in the community: A survey study | MS. WONG KA YI |
| 2025.787 | The effect of using transfer belt in assisting patient handling among physiotherapists and physiotherapy students | Miss WONG KA YIU |
| 2012.293 | Effects of external counterpulsation therapy on corticomotor excitability and motor function recovery in patients with subacute stroke | Professor WONG KA-SING |
| 2023.308 | Application of caregiver intervention program for Chinese dementia patients’ caregiver in Hong Kong |
Ms. WONG Karen Wing Sze 黃詠詩 |
| 2026.081 | Retrospective Review of Lenvatinib Use in Patients with RAI-Refractory Differentiated Thyroid Cancer | Dr. Wong Kenneth |
| 2023.661 | Patient and Healthcare Practitioner PrEferences for Treatments in Advanced RCC (PEAR) | Dr. WONG Kenneth Chun Wai |
| 2025.292 | The real-world incidence of major adverse cardiovascular events (MACEs) in metastatic prostate cancer patients receiving androgen receptor pathway inhibitors (ARPIs) – a territory-wide retrospective study. | Dr. WONG Kenneth Chun Wai |
| 2026.082 | Clinical Outcomes of Avelumab Maintenance Therapy in Locally Advanced and Metastatic Urothelial Carcinoma: Real-World Evidence from Hong Kong. | Dr. WONG Kenneth Chun Wai |
| 2025.070 | Personalized Prediction of Acute Genitourinary Toxicities of Prostate Stereotactic Body Radiotherapy: A Combined Retrospective-Prospective Study | Dr. WONG Kenneth Chun Wai |
| 2024.220 | MK-5684-003: A Phase 3 Randomized, Open-label Study of MK-5684 Versus Alternative Abiraterone Acetate or Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) Previously Treated With Next-generation Hormonal Agent (NHA) and Taxane-based Chemotherapy (OMAHA-003) | Dr. WONG Kenneth Chun Wai |
| 2024.696 | Read-world treatment patterns and clinical outcomes of locally advanced and metastatic urothelial carcinoma in Hong Kong | Dr. WONG Kenneth Chun Wai |
| 2026.090 | Evaluation of treatment outcomes of non-metastatic nasopharyngeal carcinoma treated with contemporary precision radiotherapy – A territory-wide study in Hong Kong | Dr. Wong Kenneth Chun Wai |
| 2024.200 | Radiation-associated primary hypothyroidism in head and neck cancer patients: Multi-center development and validation of a prediction model using radiomics and radiation dosiomics analyses | Dr. WONG Kenneth Chun Wai |
| 2024.627 | PSMAcTION: A phase II/III, open-label, international, multi-center, randomized study of AAA817 versus standard of care in the treatment of adult participants with PSMA-positive metastatic castration-resistant prostate cancer who progressed on or after [177Lu]Lu-PSMA targeted therapy. | Dr. WONG Kenneth Chun Wai |
| 2016.418 | The use of post-ablation stimulated thyroglobulin in predicting clinical outcomes in differentiated thyroid carcinoma – what cutoff value should we use? |
Dr. WONG Kenneth Chun Wai 王俊威 |
| 2020.412 | A Phase III Double-Blind, Randomised, Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib + Abiraterone Versus Placebo + Abiraterone as Treatment for Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Characterised by PTEN deficiency (CAPItello-281) |
Dr. WONG Kenneth Chun Wai 王俊威醫生 |
| 2026.227 | Personalized Prediction of Toxicities and Clinical Outcomes of Prostate Conventional and Moderately Hypofractionated Radiotherapy – A Retrospective Study | Dr. Wong Kenneth Chun Wai |
| 2026.232 | AcTFirst: A phase III, open-label, multi-center, randomized study comparing AAA817+ARPI versus standard of care in adult participants with PSMA-positive metastatic castration resistant prostate cancer | Dr. WONG Kenneth Chun Wai |
| 2022.458 | PSMAddition: An International Prospective Open-label, Randomized, Phase III Study comparing ¹⁷⁷Lu-PSMA-617 in combination with Standard of Care, versus Standard of Care alone, in adult male patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC) |
Dr. WONG Kenneth Chun Wai 王俊威醫生 |
| 2021.640 | A Randomized Open-Label Phase III Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Subjects with Metastatic or Locally Advanced Unresectable Urothelial Cancer |
Dr. WONG Kenneth Chun Wai 王俊威 |
| 2021.481 | FGFR alteration rate and treatment outcomes in muscle-invasive and metastatic urothelial carcinoma (mUC) in Hong Kong. |
Dr. WONG Kenneth Chun Wai 王俊威 |
| 2017.411 | The Neurocognitive Profile of Individuals with Irritable Bowel Syndrome |
Dr. WONG Kenneth Man Fung 黃文豐 |
| 2026.101 | Retrospective Comparative Study on Patient’s Recovery between Oxycodone and Tramadol in Knee Arthroplasty Protocol in 2024 | Dr. WONG Kevin Yat Chun |
Page 251 of 289.